lncreased risk of slippage upon disengagement of the mitotic checkpoint
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1012879 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Alma Beatrix Stier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pázmány Péter Catholic University, Faculty of Information Technology and Bionics, Budapest, Hungary. Hauptthemen laut MEDLINE: Mitosis, Models, Biological, M Phase Cell Cycle Checkpoints. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: italian association for cancer research, Hungarian National Research, Development and Innovation Office, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Drugs that impair microtubule dynamics alter microtubule-kinetochore attachment and invoke the mitotic checkpoint which arrests cells in mitosis. The arrest can last for hours, but it is leaky: cells adapt (i.e., slip out of it) and exit from mitosis. Here, we investigate the mechanism that allows cells to escape, and whether it is possible to prevent it. Based on a model of the mitotic checkpoint which includes the presence of a positive feedback loop, the escape from the arrest is described as a stochastic transition driven by fluctuations of molecular components from a checkpoint ON to a checkpoint OFF state. According to the model, drug removal further facilitates adaptation, a prediction we confirmed in budding yeast. The model suggests two ways to avoid adaptation: inhibition of APC/C and strengthening the mitotic checkpoint. We confirmed experimentally that both alterations decrease the chance of cells slipping out of mitosis, during a prolonged arrest and after washing out the drug. Our results may be relevant for increasing the efficiency of microtubule depolymerizing drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pázmány Péter Catholic University, Faculty of Information Technology and Bionics, Budapest, Hungary.
- IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
- Université de Bordeaux, CNRS, ImmunoConcEpT, UMR5164, F-33000, Bordeaux, France.
ORCID-Profile: Paolo Bonaiuti, Andrea Ciliberto
Förderung
- italian association for cancer research
- Hungarian National Research, Development and Innovation Office
- Associazione Italiana per la Ricerca sul Cancro
- Suma-Nesi family
- National Research, Development and Innovation Office
Zitieren
APA
Stier, A. B., Bonaiuti, P., Juhász, J., Gross, F., & Ciliberto, A. (2025). lncreased risk of slippage upon disengagement of the mitotic checkpoint. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012879
Vancouver
Stier AB, Bonaiuti P, Juhász J, Gross F, Ciliberto A. lncreased risk of slippage upon disengagement of the mitotic checkpoint. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1012879
BibTeX
@article{Stier2025,
author = {Stier, Alma Beatrix and Bonaiuti, Paolo and Juhász, János and Gross, Fridolin and Ciliberto, Andrea},
title = {lncreased risk of slippage upon disengagement of the mitotic checkpoint},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1012879}
}
EUVIMED